Your browser doesn't support javascript.
loading
A phase IA dose-escalation study of PHI-101, a new checkpoint kinase 2 inhibitor, for platinum-resistant recurrent ovarian cancer.
Park, Soo Jin; Chang, Suk-Joon; Suh, Dong Hoon; Kong, Tae Wook; Song, Heekyoung; Kim, Tae Hun; Kim, Jae-Weon; Kim, Hee Seung; Lee, Sung-Jong.
Affiliation
  • Park SJ; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080, Republic of Korea.
  • Chang SJ; Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Suh DH; Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.
  • Kong TW; Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Song H; Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero Seocho-gu, Seoul, 06591, Republic of Korea.
  • Kim TH; Department of Obstetrics and Gynecology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea.
  • Kim JW; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080, Republic of Korea.
  • Kim HS; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080, Republic of Korea. bboddi0311@snu.ac.kr.
  • Lee SJ; Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero Seocho-gu, Seoul, 06591, Republic of Korea. orlando@catholic.ac.kr.
BMC Cancer ; 22(1): 28, 2022 Jan 03.
Article in En | MEDLINE | ID: mdl-34980026
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Checkpoint Kinase 2 / Antineoplastic Agents, Immunological / Immune Checkpoint Inhibitors / Neoplasm Recurrence, Local Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Checkpoint Kinase 2 / Antineoplastic Agents, Immunological / Immune Checkpoint Inhibitors / Neoplasm Recurrence, Local Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication: Reino Unido